Huoxue Jiegu Compound Capsule (HXJGCC) enhances tibial fracture healing by promoting angiogenesis and improving the local microvascular environment. This study identifies key molecular pathways involved in the healing process, highlighting the multi-target therapeutic effects of HXJGCC.
Background
Fracture healing is a complex process that relies on the interaction of vascular, skeletal, and neural systems. Angiogenesis is crucial for providing oxygen and nutrients, as well as recruiting progenitor cells necessary for bone repair. Understanding the mechanisms that enhance fracture healing can lead to improved clinical outcomes, particularly in cases of delayed union or nonunion.
Data Highlights
Parameter
Result
Active Compounds Identified
209
Overlapping Targets
185
Key Hub Targets
AKT1, STAT3, IL6, BCL2, EGFR, JUN
Angiogenesis-Related Genes Upregulated
AKT1, STAT3, IL6, EGFR
Key Findings
HXJGCC significantly increases vascular density in the fracture region.
Key hub targets involved in angiogenesis include AKT1, STAT3, and IL6.
Molecular docking shows stable interactions between HXJGCC compounds and target proteins.
Activation of HIF-1/PI3K–Akt pathways is crucial for enhancing angiogenesis.
In vivo experiments confirm the upregulation of angiogenesis-associated genes.
Clinical Implications
The findings suggest that HXJGCC could be integrated into clinical practice to enhance fracture healing, particularly in patients at risk for delayed union. Clinicians should consider the role of angiogenesis in fracture management and explore multi-target therapeutic strategies.
Conclusion
HXJGCC promotes tibial fracture healing through enhanced angiogenesis and improved microvascular conditions, providing a promising avenue for therapeutic intervention in bone regeneration.
